These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37156587)

  • 21. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome.
    Vlieger AM; van den Berg MM; Menko-Frankenhuis C; Bongers ME; Tromp E; Benninga MA
    Am J Gastroenterol; 2010 Jan; 105(1):213-8. PubMed ID: 19861956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypnotherapy for treatment of irritable bowel syndrome.
    Webb AN; Kukuruzovic RH; Catto-Smith AG; Sawyer SM
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005110. PubMed ID: 17943840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial.
    Kim JI; Kim P; Lee JH; Kim YJ; Yang NR; Baeg MK; Choi JS; Kim HJ; Kim J; Sunwoo YY; Lee JH; Ha H; Park TY
    BMJ Open; 2017 Dec; 7(11):e018362. PubMed ID: 29196484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of analgesic ear drops as add-on treatment to oral analgesics in children with acute otitis media: study protocol of the OPTIMA pragmatic randomised controlled trial.
    de Sévaux JLH; Damoiseaux RAMJ; Hullegie S; Sanders EAM; de Wit GA; Zuithoff NPA; Yardley L; Anthierens S; Little P; Hay AD; Schilder AGM; Venekamp RP
    BMJ Open; 2023 Feb; 13(2):e062071. PubMed ID: 36813504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial.
    Sun JW; Sun ML; Li D; Zhao J; Shi SH; Li HX; Liu HM; Gao JX; Hu Y; Zheng H; Wang X; Xue RD; Feng X; Yu SG; Li ZG
    Trials; 2021 Oct; 22(1):719. PubMed ID: 34666815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.
    Miller V; Carruthers HR; Morris J; Hasan SS; Archbold S; Whorwell PJ
    Aliment Pharmacol Ther; 2015 May; 41(9):844-55. PubMed ID: 25736234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM; Chalder T; McCrone P; Darnley S; Knapp M; Jones RH; Wessely S
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual Costs of Care for Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, and Functional Abdominal Pain Syndrome.
    Hoekman DR; Rutten JM; Vlieger AM; Benninga MA; Dijkgraaf MG
    J Pediatr; 2015 Nov; 167(5):1103-8.e2. PubMed ID: 26329806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Talking in primary care (TIP): protocol for a cluster-randomised controlled trial in UK primary care to assess clinical and cost-effectiveness of communication skills e-learning for practitioners on patients' musculoskeletal pain and enablement.
    Bishop FL; Cross N; Dewar-Haggart R; Teasdale E; Herbert A; Robinson ME; Ridd MJ; Mallen C; Clarson L; Bostock J; Becque T; Stuart B; Garfield K; Morrison L; Pollet S; Vennik J; Atherton H; Howick J; Leydon GM; Nuttall J; Islam N; Lee PH; Little P; Everitt HA
    BMJ Open; 2024 Mar; 14(3):e081932. PubMed ID: 38508652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.
    Palsson OS
    Am J Clin Hypn; 2015 Oct; 58(2):134-58. PubMed ID: 26264539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).
    Löwe B; Nestoriuc Y; Andresen V; Vettorazzi E; Zapf A; Hübener S; Maehder K; Peters L; Lohse AW
    BMJ Open; 2022 Jun; 12(6):e059529. PubMed ID: 35701050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study).
    D'Silva A; Marshall DA; Vallance J; Nasser Y; Rajagopalan V; MacKean G; Raman M
    BMJ Open; 2022 May; 12(5):e059604. PubMed ID: 35618329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
    Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for a randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain.
    Levy RL; Murphy TB; van Tilburg MAL; Kuklinski MR; Bailey JA; Aalfs H; Badillo I; Diakhate H; Palermo TM
    Trials; 2024 Aug; 25(1):549. PubMed ID: 39160566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial.
    Roberts L; Wilson S; Singh S; Roalfe A; Greenfield S
    Br J Gen Pract; 2006 Feb; 56(523):115-21. PubMed ID: 16464325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial.
    Pei LX; Geng H; Chen H; Wu XL; Chen L; Zhou JL; Ju L; Lu G; Xu WL; Qin S; Guo J; Yang EM; Sun JH
    Trials; 2018 Oct; 19(1):529. PubMed ID: 30285891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
    Hurych J; Vejmelka J; Hlinakova L; Kramna L; Larionov V; Kulich M; Cinek O; Kohout P
    BMJ Open; 2022 Jun; 12(6):e056594. PubMed ID: 35760542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strengthening Care for Children (SC4C): protocol for a stepped wedge cluster randomised controlled trial of an integrated general practitioner-paediatrician model of primary care.
    Khano S; Sanci L; Woolfenden S; Zurynski Y; Dalziel K; Liaw ST; Boyle D; Freed GL; Moore C; Hodgins M; Le J; Morris TM; Germano S; Wheeler K; Lingam R; Hiscock H
    BMJ Open; 2022 Sep; 12(9):e063449. PubMed ID: 36171040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.